Follow Slashdot blog updates by subscribing to our blog RSS feed

 



Forgot your password?
typodupeerror
×
Medicine

Experts Decry Randomized Ebola Treatment Trials As Unethical, Impractical 193

New submitter Strangely Familiar writes "A letter in the Lancet calls for alternatives to randomized trials for Ebola treatments: "Leading health experts today urge the deployment of alternative trial designs to fast-track the evaluation of new Ebola treatments. In a letter to The Lancet, 17 senior health professionals and medical ethicists, from Africa, Europe, and USA, argue that although randomised controlled trials (RCTs) provide robust evidence in most circumstances, the lack of effective treatment options for Ebola, high mortality with the current standard of care, and the paucity of effective health care systems in the affected regions means that alternative trial designs need to be considered."
This discussion has been archived. No new comments can be posted.

Experts Decry Randomized Ebola Treatment Trials As Unethical, Impractical

Comments Filter:
  • If they are serious they really need to get more big names, institutions, and ethicists on board. A lot more.

    There has already been support for basically using time to create control groups, so this is much less of an issue than it could be.

  • by gweihir ( 88907 ) on Saturday October 11, 2014 @04:21PM (#48120967)

    Seriously, starting to experiment with uncertain approaches in a time of crisis is about the most stupid thing that can be done. Stick to what is known to work, there is no time to come up with anything better. If something better had been found in centuries of research into medical methods, then it would be the standard-approach. There is nothing. There will not be anything new even if you debate that question to death now.

    This continues the series of incompetence, misinformation, self-aggrandizement and general fuck-ups that have become the signature of the fight against Ebola this time.

    • by Richy_T ( 111409 ) on Saturday October 11, 2014 @04:45PM (#48121097) Homepage

      But randomized trials were designed to be used in a certain set of circumstances. The question is whether these circumstances fall outside of what those would be applicable to and what would be the appropriate protocol if they're not. Being too rigid can be a bad thing but also things should not be done in a knee-jerk fashion.

      • by gweihir ( 88907 ) on Saturday October 11, 2014 @04:52PM (#48121151)

        Any more meaningless generalities to contribute? The field is not static or rigid. The problem is just that generating and validating new drug-trial methods takes decades and cannot really be sped-up. The whole reason we have this gold-standard of randomized trials is that all else has failed. The worst was always the physician on the ground deciding about it, as they have a strong, well-known (and understandable) tendency to always favor their own patients and an inability to clearly see what is happening as a result. That is fine as it is, of course doctors should be strong allies to their patients and try whatever is possible if the patient wants that. It is also catastrophic when objective information about effectiveness or its absence of some treatment is critically needed. All this messing around that these people propose will in the end only cause more victims, potentially a lot more.

    • Seriously, starting to experiment with uncertain approaches in a time of crisis is about the most stupid thing that can be done. Stick to what is known to work, there is no time to come up with anything better.

      It's not a question of experimentation with uncertain approaches. The alternatives are all well-understood... actually the mathematics is straightforward enough that the characteristics of virtually any approach you can invent can easily be calculated.

      The question is whether they should use the approach that provides the fastest route to a given level of certainty at the expense of deliberately leaving a significant percentage of sufferers untreated, or whether to use other methods that provide the treatm

      • by gweihir ( 88907 )

        No, you cannot "easily calculate" the mathematics of an alternate approach. In a clinical trial, you _create_ the experimental conditions and that is the only reason that you know them and can do calculations. Sure, if you have all data, then modeling is easy. You will not even get reasonable approximations in the situation at hand. Remember that hospitals refuse treatment to sick and dying people because they are full? Remember that people there bury their dead themselves? Remember that conditions are bad

    • by khchung ( 462899 )

      Seriously, starting to experiment with uncertain approaches in a time of crisis is about the most stupid thing that can be done.

      But that is "doing something"! Haven't you heard of the First Rule of Bad Decision Making yet?

      1. "We must do something!"
      2. "Here is something."
      3. "Let's do it!"

      During a "crisis", doing nothing or doing things the same way you do normally (for whatever reason), is a mortal sin in the eyes of many PHB types.

      • by gweihir ( 88907 )

        Indeed. Unfortunately, if this goes seriously wrong, it is not just one incompetent tribe that gets wiped out this time.

      • by rtb61 ( 674572 )

        In this case, one of the most dangerous things you can do is partially apply a cure. Allowing people who have already been treated to remain in close contact with those still infected and resulting in re-infection is the surest way to develop treatment resistance in the targeted infectious agent. Stockpiles of any successful treatment must first be built up in countries not yet infected so that any appearance of the infection can be rapidly treated. Once those stockpiles are built upon, stockpiles to be de

    • by chooks ( 71012 )

      So how would you do an RCT for something like Ebola, a disease that really only manifests itself when it starts to spread? Would you ask for volunteers to be infected outside of an outbreak in ordered to test efficacy/safety? Is there an IRB board in the country that would authorize something like this?

      I actually do agree that you don't want to get all Mavericky with drug experimentation. At a certain point though you need patients with the disease to test efficacy and safety. If the only time you have pa

  • I understand their concern, but ZMapp hasn't even passed stage 1 clinical trials. We don't know if it's safe for humans or not. It could kill more people than it helps. Having randomized trials is how we establish the safety level of the drug.

    It may be useful to 'fastrack' the drug through stage 2 trials, since by that point we know it won't kill you.
    • by gweihir ( 88907 )

      The available ZMapp was wasted in a worthless political demonstration "that something can be done". In the end, it is likely that this utterly selfish and stupid approach will make things significantly worse.

      • Re:ZMapp (Score:4, Insightful)

        by phantomfive ( 622387 ) on Saturday October 11, 2014 @04:41PM (#48121067) Journal
        Oh yeah, add that to the list of problems. There isn't enough ZMapp to give it to everyone, even if it were a good idea. Since you don't have enough for everyone, why on earth wouldn't you do a randomized trial?
        • by gweihir ( 88907 )

          As I said, political reasons. The US administration wanted to demonstrate that it "can do", no matter the cost. At this time there is no ZMapp left, AFAIK, and more will take months to produce. And due to this initial stupidity, we have zero knowledge whether it is even a good idea to use.

        • by silfen ( 3720385 )

          Since you don't have enough for everyone, why on earth wouldn't you do a randomized trial?

          Because randomized trials are difficult to set up properly. It might well be better just to give ZMapp based on availability and common sense clinical judgment and then analyze the data, including natural controls, retroactively.

          • by gweihir ( 88907 )

            That does not work. It is well-established that it does not work. Really, maybe do a tiny bit of basic research before spouting utter nonsense?

            • by silfen ( 3720385 )

              That does not work. It is well-established that it does not work. Really, maybe do a tiny bit of basic research before spouting utter nonsense?

              You don't know what you are talking about. Much, if not most, of medical research is based on natural experiments and retrospective analyses. FDA-approved drugs are the exception, not the rule.

              Double blind clinical trials are the standard for FDA drug approval because for most diseases, delays and costs don't matter that much: there are already adequate treatments. J

      • The available ZMapp was wasted in a worthless political demonstration "that something can be done".

        Quote so. There were only a few doses available and without a trial of statistically significant size we cannot possible know if this treatment was effective. Ebola is serious but it doesn't kill everyone it infects. So if you give a treatment to a tiny group of people you have absolutely no way to know if the treatment was effective. You have wasted time and money and hope and learned absolutely nothing in the process. It's idiotic.

    • by silfen ( 3720385 )

      I understand their concern, but ZMapp hasn't even passed stage 1 clinical trials. We don't know if it's safe for humans or not.

      Who cares what "we" know? Why not leave the decision up to the individual involved?

      • by sjbe ( 173966 )

        Who cares what "we" know? Why not leave the decision up to the individual involved?

        Because people fearing for their life tend to make remarkably dumb decisions, particularly since few of them are actually knowledgeable regarding the facts involved. Because even if we give one person the drug we will have absolutely no way to know if it was effective because ebola doesn't kill everyone it infects. Was it the drug or some other factor that saved them?

        We do things the way we do them for extremely good reasons. Rushing things actually ends up hindering things in the long run.

  • Translation... (Score:4, Insightful)

    by sjbe ( 173966 ) on Saturday October 11, 2014 @04:38PM (#48121043)

    argue that although randomised controlled trials (RCTs) provide robust evidence in most circumstances, the lack of effective treatment options for Ebola, high mortality with the current standard of care, and the paucity of effective health care systems in the affected regions means that alternative trial designs need to be considered."

    Translation:
    Even though randomized trials are the gold standard for determining whether a treatment is effective or not, these places have shitty health care systems so we think should do something else now that we know is a bad idea even though it will be detrimental in the long run rather than engage in the hard work that will really solve the problem.

    Conveniently these "alternative trial designs" are not detailed in any way. Doing something different for the sake of doing something different is rarely a good idea.

    We use randomized trials for VERY good reasons. If we push a bunch of experimental treatments out there it's possible we may save some lives but it is more likely we will accomplish nothing and even worse we will learn nothing in the process. Yes some people are going to die from ebola while we develop treatments. This is the cold hard fact of medicine - we sacrifice some so that a greater number may benefit eventually. You can try taking shortcuts but the odds are very long against them working and even worse you run a high risk of sacrificing future patients on the altar of compassion.

    I get that people are dying and my heart goes out to them. But we do things the way we do them for very good reasons and the middle of a (minor overblown) crisis is hardly the time to start throwing out what we know for a fact works.

    • Re: (Score:3, Insightful)

      by TWX ( 665546 )
      Between the high mortality rate and the apparently high transmission rate, coupled with cultural structures that are making the likelihood of spreading the disease post-mortem exceedingly high, they're simply desperate to find anything that will stop it. It also means that for those that are infected, there's so little chance of survival with "traditional" treatments that they have very little to lose by trying something experimental. Even if a treatment gives them cancer, or HIV, or leaves them with so
      • they're simply desperate to find anything that will stop it.

        We already know what we stop the epidemic. Appropriately executed public health policies, particularly quarantine. I understand people's fear and desperation but public health policy is not the place for panic. To use a basketball analogy these people are proposing taking half-court shots and hoping for the best rather than doing the hard work of actually doing what we already know will work. We are NOT going to save everyone but rushing things along is very likely to actually kill more people in the lo

        • Is quarantine working? Based on a PBS documentary, I'm not inclined to think so. The countries affected didn't have the trained medical staff needed before the outbreak and they've lost both front-line personnel and researchers to Ebola, further weakening their ability to respond. One country is already talking about trying to force families to care for their sick at home, basically guaranteeing more family members become sick, further increasing the likelihood that more people will be infected. And when
          • by Nemyst ( 1383049 )
            The quarantine isn't working because the countries are on the verge of toppling down. They can't enforce the quarantine. Thing is, we don't have that miraculous experimental treatment you mention. First of all, we don't have enough of the currently in testing treatments like ZMapp to effectively stop propagation or reassure the population. Second of all, we don't even know if that will work. You say the population needs to see an increase in the survival rate, but what if even with ZMapp it doesn't change e
            • by TWX ( 665546 )
              I'm well aware of the painfully-small supply of ZMapp and other drugs like it. My point is that if someone with good medical and/or research credentials in viruses has something that they've been researching that they think has a decent chance of making a severe dent in Ebola based on animal testing, if they can give it a go in the wild instead of in a blind study, go for it. We already have documented what happens to a control group by simply not having a treatment; we don't need to do a blind study wher
      • I'm blowing a mod point for this but my reply below (a) comes from personal experience, and (b) is why you don't drop stages in the development of medicines:

        Even if a treatment gives them cancer, or HIV, or leaves them with something like chronic fatigue syndrome, they're still going to enjoy quality of life better than they would if they're dead.

        How about an immune system that attacks its own body endlessly such that treated subjects balloon every day to twice their normal surface area, losing enough bo

      • It also means that for those that are infected, there's so little chance of survival with "traditional" treatments that they have very little to lose by trying something experimental. Even if a treatment gives them cancer, or HIV, or leaves them with something like chronic fatigue syndrome, they're still going to enjoy quality of life better than they would if they're dead.

        I would posit that the problem is not that the currently infected individual faces any fate worse than death.

        The problem is that lack of high-quality data may forestall the development of more effective therapies, which means you are condemning people infected in the future to death. This latter group seems abstract and hazy, compared to the concrete suffering we can see before us, but eventually the future becomes the now, and we'll have to deal with it.

        Researchers may well end up heading down blind alley

    • Well I would argue something different. The point of randomised controlled trials is to form a perfect control group for comparison.

      We have a pandemic which has so far been treated without the drug. For the most part we have a lot of data about the control group already. Changes in care in West Africa have had little effect on the mortality rate of victims. So why not start giving the drug to everyone and compare against historical data?

      • The point of randomised controlled trials is to form a perfect control group for comparison.

        More or less correct. You are trying to control for variables between the treated groups and the non-treated groups to see if there is a statistically significant difference in outcomes between them. If there is a better way to do this than a double-blind study, we haven't found it yet. We do use other study designs when a double-blind study isn't possible but other methods have significant problems.

        So why not start giving the drug to everyone and compare against historical data?

        Several reasons:
        1) Which drug? Do we have enough of it? Can we get it to where it is needed? Has it bee

        • by dgatwood ( 11270 )

          1) Which drug? Do we have enough of it? Can we get it to where it is needed? Has it been previously tested in humans for toxicity? Is there any reason to believe it will work beyond mere hope?

          5) Most drugs do not work. Do you REALLY want to spread already scarce resources even thinner on a long shot that probably will not work?

          Nothing is being tested without success in animal models. That's not a guarantee, but AFAIK viruses in humans replicate in basically the same way that they do in animals, so odds are

        • 1) Which drug? Do we have enough of it? Can we get it to where it is needed? Has it been previously tested in humans for toxicity? Is there any reason to believe it will work beyond mere hope?

          All of them, individually with their own studies on successes. As for has it been tested, we are beyond that stage. Once we get to the point where we are arguing the specific scientific method of a clinical trial we can guarantee that we're at the point where the drug has matured beyond this question. I.e. it's already worked in labs / animals and been presumed safe to administer. (Despite what people think, signing up for clinical drug trials is actually incredibly safe).

          2) We do NOT have particularly good information in the historical record. The medical records in the affected areas are quite certain to be of poor quality. So you lose a LOT of information that is relevant for making comparisons and you do not have a particularly good control group.

          My argument is that you don't need

    • Conveniently these "alternative trial designs" are not detailed in any way. Doing something different for the sake of doing something different is rarely a good idea.

      The alternative I've repeatedly seen mentioned is the stepped wedge trial.

      Basically, you take your sample, create subgroups of random patients, then give the treatment to one group at a time.

      This allows you to use the upcoming subgroups as controls, while avoiding the ethical problems of denying people treatment. [wikipedia.org]

      The ethics are something reasonable people can and do disagree about. The problem in this particular situation is that you're trying to run a clinical trial during an active pandemic against a disea

    • by Livius ( 318358 )

      I suspect these 'experts' are just panicky people who an incompetent journalist mistook for actual experts.

      If anything people genuinely interested in the cure will *not* want to compromise actual clinical trials.

      Perhaps some alternatives could be tried in parallel, and - by random chance - they might help, but they will be nothing more than folk remedies until there are proper trials.

  • by russotto ( 537200 ) on Saturday October 11, 2014 @04:45PM (#48121103) Journal

    Randomized trials worked just fine for syphilis.

  • by 93 Escort Wagon ( 326346 ) on Saturday October 11, 2014 @04:46PM (#48121111)

    The signatories to that letter in Lancet are willing to shoulder any monetary and/or criminal penalties that, in the future, come about because doctors and pharmaceutical makers haven't followed eatablished best practices in pursuit of effective Ebola treatments.

  • drive-by doctoring is Unethical, Impractical but legal and you are on the hook for the fees some at out of network rates.

  • WHO is already looking at stepped wedge trials [umn.edu]

  • It's not ethical to administer treatment until we have reason to believe it's more likely to do good than harm. With top of the line supportive care, ebola patients seem to have about even odds to pull through. Giving them something toxic or using limited money on unproven medication rather than access to good supportive care could well jeopardize those odds. Initial trials should be done on just big enough groups to establish necessary statistical confidence.

    Now if side effects are few and financing is not

    • by Nemyst ( 1383049 )
      It's a tough balancing act for sure, but there's an assumption that you're making here: those people do NOT have access to top of the line supportive care. If survival rate is 20% with little to no care (which is what is currently happening in Western Africa) but (hypothetically) 30% with the experimental treatment regardless of care, what do you do? You're still increasing their survival chance by 50%, but it could also kill people who'd live with top care without the drug.

      Never forget the big picture in
  • Randomized trials are essential withholding potential treatment from some suffering patients, to satisfy some of the experimenters' goals.
    So why not allow the experimental product to be administered outside of the trial, having only passed safety standards? That can provide solid evidence for a large category of illnesses (those that people are not known to recover from spontaneously).

    Then, if some folks want more rigorous evidence of efficacy, they are welcome to find patients who accept to participat
  • Studies without control group that use a placebo will prove nothing about a treatment, but are they unethical? Will it be ethical to give a placebo to someone suffering a deadly sickness?
    • by dgatwood ( 11270 )

      That's simply not true. Non-placebo-controlled open clinical trials are used all the time to determine the efficacy of treatment. They aren't nearly as airtight as double-blinded, placebo-controlled studies (because of the placebo effect), but to say that they prove nothing is overstating things quite a bit, particularly in situations where success or failure is black-and-white (because the patient either died or didn't).

      • But without placebo group, if the patient recovers, how can you tell this is because of the treatment?
  • I have a friend that worked at the Stanford medical center's pediatric intensive care unit, where his patients were often flown in/helicoptered from all over the state. There are certain diseases that have a 100% mortality rate in children, where they could be fine two weeks before, and near death when he gets them. He developed a cure that saves about half the kids, and attributes most of the lost ones for not getting then to him fast enough. Everywhere else in the world they die. Stanford, being a rese

  • It's time we came up with a twenty-frst century alternative to the randomized trial, like creating a supercomputer model of the human body to test drugs agaionst,

    Giving half your test population of cancer patients a placebo may be merely unethical, but giving half your population of Ebola patiets a placebo could take out an entire country.

Dennis Ritchie is twice as bright as Steve Jobs, and only half wrong. -- Jim Gettys

Working...